Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - NovaBay Pharmaceuticals, Inc. | nby20171231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - NovaBay Pharmaceuticals, Inc. | ex_107890.htm |
| EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc. | ex_107889.htm |
| EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc. | ex_107888.htm |
| EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc. | ex_107887.htm |
| EX-3.1 - EXHIBIT 3.1 - NovaBay Pharmaceuticals, Inc. | ex_107885.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-222625, 333-218469, 333-215680, 333-211754, 333-208985, 333-203109, 333-196764, 333-194383, 333-185998, 333-180461, 333-171981, 333-147334, 333-157041, and 333-164469), Form S-3 (File Nos. 333-211944, 333-211943 333-204998, 333-203735, 333-203112, 333-159917 and 333-180460), and Form S-1 (File No. 333-222100) of NovaBay Pharmaceuticals, Inc. of our report dated March 21, 2018, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
March 21, 2018